Efficient Messenger RNA Delivery to the Kidney Using Renal Pelvis Injection in Mice

Renal dysfunction is often associated with the inflammatory cascade, leading to non-reversible nephrofibrosis. Gene therapy has the ability to treat the pathology. However, the difficulty in introducing genes into the kidney, via either viral vectors or plasmid DNA (pDNA), has hampered its extensive...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natsuko Oyama, Maho Kawaguchi, Keiji Itaka, Shigeru Kawakami
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/fcae87e9a1ee4988aeb9d5cb3859540f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fcae87e9a1ee4988aeb9d5cb3859540f
record_format dspace
spelling oai:doaj.org-article:fcae87e9a1ee4988aeb9d5cb3859540f2021-11-25T18:40:51ZEfficient Messenger RNA Delivery to the Kidney Using Renal Pelvis Injection in Mice10.3390/pharmaceutics131118101999-4923https://doaj.org/article/fcae87e9a1ee4988aeb9d5cb3859540f2021-10-01T00:00:00Zhttps://www.mdpi.com/1999-4923/13/11/1810https://doaj.org/toc/1999-4923Renal dysfunction is often associated with the inflammatory cascade, leading to non-reversible nephrofibrosis. Gene therapy has the ability to treat the pathology. However, the difficulty in introducing genes into the kidney, via either viral vectors or plasmid DNA (pDNA), has hampered its extensive clinical use. Messenger RNA (mRNA) therapeutics has recently attracted attention as alternative gene therapies. mRNA allows protein production into post-mitotic cells without the need for transport to the nuclei in the target cells. However, few studies have reported the delivery of mRNA to the kidney. In this study, we attempted to deliver mRNA to the kidney based on the principle of pressure stimulation, by administering mRNA-loaded polyplex nanomicelles via a renal pelvis injection, directly into the kidney. Compared with the administration of naked plasmid DNA (pDNA) and naked mRNA, the mRNA-loaded nanomicelles diffusely induced protein expression in a greater number of cells at the tubular epithelium for some days. The plasma creatinine (Cre) and blood urea nitrogen (BUN) levels after the administration remained similar to those of the sham-operated controls, without marked changes in histological sections. The safety and efficacy of mRNA-loaded nanomicelles would make distinct contributions to the development of mRNA therapeutics for the kidney.Natsuko OyamaMaho KawaguchiKeiji ItakaShigeru KawakamiMDPI AGarticlemessenger RNA (mRNA)mRNA therapeuticspolyplex nanomicellekidneyrenal pelvis injectionhydrodynamic injectionPharmacy and materia medicaRS1-441ENPharmaceutics, Vol 13, Iss 1810, p 1810 (2021)
institution DOAJ
collection DOAJ
language EN
topic messenger RNA (mRNA)
mRNA therapeutics
polyplex nanomicelle
kidney
renal pelvis injection
hydrodynamic injection
Pharmacy and materia medica
RS1-441
spellingShingle messenger RNA (mRNA)
mRNA therapeutics
polyplex nanomicelle
kidney
renal pelvis injection
hydrodynamic injection
Pharmacy and materia medica
RS1-441
Natsuko Oyama
Maho Kawaguchi
Keiji Itaka
Shigeru Kawakami
Efficient Messenger RNA Delivery to the Kidney Using Renal Pelvis Injection in Mice
description Renal dysfunction is often associated with the inflammatory cascade, leading to non-reversible nephrofibrosis. Gene therapy has the ability to treat the pathology. However, the difficulty in introducing genes into the kidney, via either viral vectors or plasmid DNA (pDNA), has hampered its extensive clinical use. Messenger RNA (mRNA) therapeutics has recently attracted attention as alternative gene therapies. mRNA allows protein production into post-mitotic cells without the need for transport to the nuclei in the target cells. However, few studies have reported the delivery of mRNA to the kidney. In this study, we attempted to deliver mRNA to the kidney based on the principle of pressure stimulation, by administering mRNA-loaded polyplex nanomicelles via a renal pelvis injection, directly into the kidney. Compared with the administration of naked plasmid DNA (pDNA) and naked mRNA, the mRNA-loaded nanomicelles diffusely induced protein expression in a greater number of cells at the tubular epithelium for some days. The plasma creatinine (Cre) and blood urea nitrogen (BUN) levels after the administration remained similar to those of the sham-operated controls, without marked changes in histological sections. The safety and efficacy of mRNA-loaded nanomicelles would make distinct contributions to the development of mRNA therapeutics for the kidney.
format article
author Natsuko Oyama
Maho Kawaguchi
Keiji Itaka
Shigeru Kawakami
author_facet Natsuko Oyama
Maho Kawaguchi
Keiji Itaka
Shigeru Kawakami
author_sort Natsuko Oyama
title Efficient Messenger RNA Delivery to the Kidney Using Renal Pelvis Injection in Mice
title_short Efficient Messenger RNA Delivery to the Kidney Using Renal Pelvis Injection in Mice
title_full Efficient Messenger RNA Delivery to the Kidney Using Renal Pelvis Injection in Mice
title_fullStr Efficient Messenger RNA Delivery to the Kidney Using Renal Pelvis Injection in Mice
title_full_unstemmed Efficient Messenger RNA Delivery to the Kidney Using Renal Pelvis Injection in Mice
title_sort efficient messenger rna delivery to the kidney using renal pelvis injection in mice
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/fcae87e9a1ee4988aeb9d5cb3859540f
work_keys_str_mv AT natsukooyama efficientmessengerrnadeliverytothekidneyusingrenalpelvisinjectioninmice
AT mahokawaguchi efficientmessengerrnadeliverytothekidneyusingrenalpelvisinjectioninmice
AT keijiitaka efficientmessengerrnadeliverytothekidneyusingrenalpelvisinjectioninmice
AT shigerukawakami efficientmessengerrnadeliverytothekidneyusingrenalpelvisinjectioninmice
_version_ 1718410871724572672